Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection
- 1 December 2003
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 115 (8) , 632-641
- https://doi.org/10.1016/j.amjmed.2003.07.007
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Impact of Adherence and Highly Active Antiretroviral Therapy on Survival in HIV-Infected PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2002
- Effect of adherence to newly initiated antiretroviral therapy on plasma viral loadAIDS, 2001
- Limited Patient Adherence to Highly Active Antiretroviral Therapy for HIV-1 Infection in an Observational Cohort StudyArchives of internal medicine (1960), 2001
- Adherence to Highly Active Antiretroviral Therapy Predicts Virologic Outcome at an Inner‐City Human Immunodeficiency Virus ClinicClinical Infectious Diseases, 2001
- Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV InfectionAnnals of Internal Medicine, 2000
- 3-Year Suppression of HIV Viremia with Indinavir, Zidovudine, and LamivudineAnnals of Internal Medicine, 2000
- Mechanisms of Virologic Failure in Previously Untreated HIV-Infected Patients From a Trial of Induction-Maintenance TherapyJAMA, 2000
- Highly Active Antiretroviral Therapy in a Large Urban Clinic: Risk Factors for Virologic Failure and Adverse Drug ReactionsAnnals of Internal Medicine, 1999
- Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort studyThe Lancet, 1999
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998